TrialCritical care (London, England)2012

Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study.

Bertrand Guidet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.